Retractable Technologies, Inc. (NYSE:RVP – Get Free Report) CEO Thomas J. Shaw acquired 15,363 shares of the company’s stock in a transaction dated Wednesday, April 17th. The shares were purchased at an average cost of $1.03 per share, with a total value of $15,823.89. Following the acquisition, the chief executive officer now owns 14,352,831 shares of the company’s stock, valued at approximately $14,783,415.93. The acquisition was disclosed in a filing with the SEC, which is accessible through this link.
Retractable Technologies Price Performance
Shares of RVP traded down $0.02 during mid-day trading on Thursday, hitting $1.02. 76,907 shares of the company traded hands, compared to its average volume of 78,911. Retractable Technologies, Inc. has a one year low of $0.95 and a one year high of $1.88. The company has a current ratio of 8.28, a quick ratio of 6.41 and a debt-to-equity ratio of 0.01. The business has a 50-day moving average of $1.21 and a 200 day moving average of $1.16. The stock has a market capitalization of $30.54 million, a price-to-earnings ratio of -4.29 and a beta of 2.11.
Institutional Trading of Retractable Technologies
Several hedge funds have recently modified their holdings of RVP. Jane Street Group LLC bought a new stake in shares of Retractable Technologies during the fourth quarter valued at approximately $27,000. Cubist Systematic Strategies LLC bought a new position in Retractable Technologies in the second quarter valued at approximately $40,000. Dimensional Fund Advisors LP bought a new position in Retractable Technologies in the third quarter valued at approximately $52,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main bought a new position in Retractable Technologies in the second quarter valued at approximately $54,000. Finally, Virtu Financial LLC bought a new position in Retractable Technologies in the second quarter valued at approximately $57,000. 7.58% of the stock is owned by institutional investors.
Analyst Ratings Changes
Read Our Latest Stock Analysis on RVP
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
See Also
- Five stocks we like better than Retractable Technologies
- The 3 Best Retail Stocks to Shop for in August
- Comprehensive PepsiCo Stock Analysis
- Manufacturing Stocks Investing
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What Are Trending Stocks? Trending Stocks Explained
- Bear Market Funds to Watch This Year
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.